N
IOVA icon

Natixis’s Iovance Biotherapeutics IOVA Stock Holding History

Natixis’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.3K Buy
+7,503
New +$24K ﹤0.01% 1001
2025
Q4 		– Sell
-20,479
Closed -$44.4K – 1218
2025
Q3 		$44.4K Sell
20,479
-23,801
-54% -$56.2K ﹤0.01% 940
2025
Q2 		$76.2K Buy
+44,280
New +$110K ﹤0.01% 852
2023
Q3 		– Sell
-15,989
Closed -$113K – 1063
2023
Q2 		$113K Buy
15,989
+14,949
+1,437% +$107K ﹤0.01% 790
2023
Q1 		$6.35K Hold
1,040
– – ﹤0.01% 908
2022
Q4 		$6.65K Buy
+1,040
New +$8.12K ﹤0.01% 1013
2022
Q2 		– Sell
-143,040
Closed -$2.38M – 1254
2022
Q1 		$2.38M Buy
+143,040
New +$2.21M 0.01% 714
2021
Q3 		– Sell
-11,131
Closed -$290K – 1242
2021
Q2 		$290K Buy
+11,131
New +$289K ﹤0.01% 787

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return